Back to Companies
Actinium Pharmaceuticals, Inc.
ATNMNYSECIK: 0001388320
Actinium Pharmaceuticals, Inc. (ATNM) shows 11 recent insider filings from 9 insiders, with no open-market buying or selling. SETH SANDESH (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $1.1M by SETH SANDESH. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$2.0M
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
11 loaded
| Oct 16 | ATNM Actinium Pharmaceuticals, Inc. | David Matthew T | Chief Financial Officer | Other | $0 |
| Oct 16 | ATNM Actinium Pharmaceuticals, Inc. | David Matthew T | Chief Financial Officer | Grant | $243.8K |
| Sep 10 | ATNM Actinium Pharmaceuticals, Inc. | Heeger Steffen Wilhem | Chief Medical Officer | Other | $0 |
| Sep 10 | ATNM Actinium Pharmaceuticals, Inc. | Kamal Adeela | Chief Scientific Officer | Other | $0 |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Almenoff June Sherie | Director | Grant | $27.0K |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | SETH SANDESH | Chief Executive Officer, Director | Grant | $1.1M |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Shetty Ajit | Director | Grant | $92.4K |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Nicholson, C. David | Director | Grant | $94.2K |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Chell Jeffrey W. | Director | Grant | $92.4K |
| Sep 4 | ATNM Actinium Pharmaceuticals, Inc. | Steinhart Richard I | Director | Grant | $94.2K |
| Aug 20 | ATNM Actinium Pharmaceuticals, Inc. | SETH SANDESH | Chief Executive Officer, Director | Tax withheld | $206.7K |
11 filings